Detalhe da pesquisa
1.
Modified CVAD and modified CBAD compared to high-dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma.
Eur J Haematol
; 98(4): 388-392, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28009447
2.
A case series using famciclovir in stem cell transplant recipients with valacyclovir hypersensitivity reactions.
J Oncol Pharm Pract
; 21(4): 305-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24714130
3.
The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
J Oncol Pharm Pract
; 20(4): 257-62, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24022408
4.
A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
J Oncol Pharm Pract
; 17(2): 91-103, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20085962
5.
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin.
Clin Lymphoma Myeloma Leuk
; 13(3): 296-301, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23313065